UnitedHealth Group Statement on Trump Administration's Drug Policy Proposal
May 11 2018 - 6:29PM
Business Wire
Today, UnitedHealth Group released the following statement on
the Trump Administration’s drug policy proposal:
“The fundamental issues with prescription drug affordability are
the high prices set by and marketing practices of pharmaceutical
manufacturers, so we welcome the Administration’s focus on reducing
drug costs. UnitedHealth Group remains committed to offering
concrete solutions to further protect consumers from rising drug
prices and building programs to help make prescription drug costs
more affordable, predictable and stable – programs like our
industry-first initiative to provide point of sale pharmacy
discounts for our commercial customers, and our application of
advanced technology to provide drug cost transparency right in the
doctor’s office.”
About UnitedHealth GroupUnitedHealth Group (NYSE: UNH) is
a diversified health and well-being company dedicated to helping
people live healthier lives and helping make the health system work
better for everyone. UnitedHealth Group offers a broad spectrum of
products and services through two distinct platforms:
UnitedHealthcare, which provides health care coverage and benefits
services; and Optum, which provides information and
technology-enabled health services. For more information, visit
UnitedHealth Group at http://www.unitedhealthgroup.com or follow
@UnitedHealthGrp on Twitter.
Click here to subscribe to Mobile Alerts for UnitedHealth
Group.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20180511005821/en/
UnitedHealth GroupL.D. Platt,
202-413-7763orOptumRxDrew Krejci, 612-716-3980
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Aug 2024 to Sep 2024
UnitedHealth (NYSE:UNH)
Historical Stock Chart
From Sep 2023 to Sep 2024